(((( NSPX ))) PATENTS ACTIVE AS OF YESTERDAY!!! 4/5/2020
Key Facts *** Mipsagargin *** is the Inspyr lead drug candidate and now Thier Partner Phyton also has thier Patent Active as of yesterday to Help the Production of thapsigargins which is the KEY INGREDIENT TO ((( MIPSAGARGIN ))) NSPX COVID-19 Novel drug to treat and or Cure...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.